1h Free Analyst Time
The over-the-counter (OTC) drug market is forecasted to grow by USD 56.1 billion during 2023-2028, accelerating at a CAGR of 6% during the forecast period. The report on the over-the-counter (OTC) drug market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by new product launches in global over-the-counter drug market, rising prevalence of diseases and OTC drug use, and favorable regulatory framework for OTC drugs.
The over-the-counter (OTC) drug market is segmented as below:
By Distribution Channel
- Offline
- Online
By Route Of Administration
- Oral
- Topical
- Parenteral
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the over-the-counter (OTC) drug market covers the following areas:
- Over-the-counter (OTC) drug market sizing
- Over-the-counter (OTC) drug market forecast
- Over-the-counter (OTC) drug market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Distribution Channel
7 Market Segmentation by Route of Administration
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global over-the-counter (OTC) drug market: Abbott Laboratories, Achelios Therapeutics Inc., AstraZeneca PLC, Bayer AG, BioGaia AB, Boehringer Ingelheim International GmbH, Bukwang Pharmaceutical Co. Ltd., Chr Hansen Holding AS, Cipla Inc., CVS Health Corp., Eli Lilly and Co., GlaxoSmithKline PLC, Johnson and Johnson Services Inc., Lupin Ltd., Mankind Pharma Ltd., Novartis AG, Pfizer Inc., Reckitt Benckiser Group PLC, Sanofi SA, and Zydus Lifesciences Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing number of geriatric population."
According to the report, one of the major drivers for this market is the new product launches in global over-the-counter drug market.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Achelios Therapeutics Inc.
- AstraZeneca Plc
- Bayer AG
- BioGaia AB
- Boehringer Ingelheim International GmbH
- Bukwang Pharmaceutical Co. Ltd.
- Chr Hansen Holding AS
- Cipla Inc.
- CVS Health Corp.
- Eli Lilly and Co.
- GlaxoSmithKline Plc
- Johnson and Johnson Services Inc.
- Lupin Ltd.
- Mankind Pharma Ltd.
- Novartis AG
- Pfizer Inc.
- Reckitt Benckiser Group Plc
- Sanofi SA
- Zydus Lifesciences Ltd.
